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Effects of Crystalline Lactose on Expression
of Sodium-dependent Glucose Transporter 
(SGLT)-1 mRNA
Supplementation of crystalline lactose increases SGLT-1 mRNA relative abundance, glucose transport to the 
basolateral compartment, and reduces the LPS-mediated inhibitory effect on glucose transport in IPEC-J2 cells.
Huyen Tran
Phillip S. Miller
Thomas E. Burkey1
Summary
A preliminary experiment was con-
ducted to evaluate the effects of crystal-
line lactose on the relative abundance of 
sodium-dependent glucose transporter 
(SGLT)-1 mRNA in vitro in model por-
cine jejunal epithelial cells (IPEC-J2). 
Cells were treated with low (28 mM) or 
high (56 mM) concentrations of lactose 
alone or in combination with lipopoly-
saccharide (LPS; 10 ng/mL). Total 
RNA and culture media samples from 
both apical and basolateral compart-
ments were harvested at 3, 6, 12, and 24 
hours following the addition of respec-
tive treatments. With respect to relative 
abundance of SGLT-1 mRNA, there 
were no interactions of lactose, LPS, and 
time; however, a main effect of lactose 
(P < 0.01) was observed. Cells treated 
with a high concentration of lactose 
had greater SGLT-1 mRNA expression 
compared to the control cells (P = 0.003) 
and low concentration lactose (P = 0.02) 
treated cells. With respect to glucose 
quantifi cation, polarization of glucose 
in the basolateral rather than in the 
apical compartment (P = 0.04) was 
observed in a time-dependent manner 
(P < 0.001). Supplementation of lac-
tose in LPS-treated cells reduced LPS-
mediated inhibitory effect on glucose 
transport from the apical to basolateral 
compartment (P = 0.07).
in cultured porcine epithelial cells 
does not exist. Thus, a preliminary 
experiment was conducted to evalu-
ate the effects of supplementation of 
crystalline lactose on glucose transport 
and expression of mRNA encoding for 
sodium-dependent glucose transporter 
(SGLT)-1 in vitro in model porcine 
jejunal epithelial cells (IPEC-J2).
Materials and Methods
IPEC-J2 Cell Cultures and Treatment 
Design
Porcine jejunal intestinal epi-
thelial cells have been characterized 
previously and are non-transformed, 
jejunal epithelial cells derived from 
neonatal pigs, and are maintained as 
a continuous culture. Cell cultures 
were maintained in DMEM-F12 
growth medium supplemented with 
insulin/transferin/Na selenite media 
supplement, epidermal growth factor, 
antibiotic, and fetal bovine serum. For 
experimentation, IPEC-J2 cells were 
seeded onto 12-well transwell cell 
culture plates and maintained in the 
above media. The cells were incubated 
for 24 hours before being washed and 
re-fed every other day for seven days 
to form a model of the gut epithelium. 
Twenty-four hours before experimen-
tation, cells were washed and re-fed 
media devoid of antibiotics. 
There were six treatments (2 × 3 
factorial) included in this experiment: 
1) control (CTL; growth media devoid 
of antibiotics); 2) CTL + Lipopolysac-
Introduction
Previous research demonstrated 
that including lactose in diets for 
nursery pigs can improve growth 
performance and gut health (i.e., 
stimulating epithelial cell prolifera-
tion and mediating benefi cial bacteria 
colonization in the gastrointestinal 
tract (GIT). However, molecular 
mechanisms for how lactose affects 
pig growth remain unclear. In the 
small intestine, lactose is hydrolyzed 
and absorbed as glucose and galactose 
via the action of lactase present along 
the brush border membrane. The 
absorption of glucose and galactose 
involves two steps mediated by the 
sodium-dependent glucose transporter 
(SGLT)-1 and glucose transporter 
(GLUT)-2. First, sugar transport is 
coupled to sodium and electrical 
gradients across the epithelial cell 
membrane providing energy for the 
infl ux of the sugars. This step is facili-
tated by SGLT-1 (an integral protein in 
the brush border membrane). Second, 
glucose and galactose are transported 
across the basolateral membrane of 
enterocytes to the blood via GLUT-2. 
The dissociation of Na+ at the cytoso-
lic surface is the rate-limiting step of 
SGLT-1 transport. Thus, SGLT-1 plays 
an important role in sugar uptake 
from the GIT lumen to enterocytes. 
Research studies have investigated 
effects of different sugars, fi ber, and 
sodium on SGLT-1 gene expression; 
however, a mechanism for how lactose 
affects expression of SGLT-1 mRNA 
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charide (LPS; 10 ng/mL); 3) CTL + 
low lactose (28 mM); 4) CTL + high 
lactose (56 mM); 5) CTL + LPS + low 
lactose (28 mM); and 6) CTL + LPS + 
high lactose (56 mM). 
Total RNA and cell culture media 
samples from both apical and baso-
lateral compartments were harvested 
at 3, 6, 12, and 24 hours following the 
addition of treatments.
RNA Isolation and Quantitative Real-
Time PCR Analysis
Total RNA was extracted and 
contaminating genomic DNA was re-
moved from all RNA samples. Samples 
were reconstituted in nuclease-free 
water and frozen for further analysis. 
The quality of RNA was assessed by 
agarose gel electrophoresis and visu-
lization of 28S and 18S rRNA bands. 
The quantity of RNA was determined 
by spectrophotometry (OD 260 nm). 
Complementary DNA (cDNA) was 
synthesized by reverse transcription 
(RT) from 1.0 μg of RNA. Reverse 
transcription reagents included 25 
mM MgCl2, 500 μM dNTP’s, 2.5 μM 
random hexamers, 0.4 U/μL Rnase 
inhibitor, 50 U/μL MultiScribe reverse 
transcriptase, and TaqMan RT buffer. 
The RT mixture was incubated at 25oC 
for 10 min, heated to 37oC for 60 min, 
and inactivated at 95oC for 5 min. Syn-
thesized cDNA was used as a template 
for real-time quantitative polymerase 
reaction (q-PCR) to quantify SGLT-1 
mRNA relative to the quantity of the 
endogenous control (18S rRNA). The 
q-PCR reaction was conducted in 
384-well plate with the SGLT-1 specific 
primers (TaqMan Gene Expression As-
says, Applied Biosystems; Assay ID No. 
Ss03394307_m1). Commercially avail-
able eukaryotic 18S rRNA primers and 
a probe were used as an endogenous 
control. The PCR reactions, run in 
triplicate wells, were carried out with 
the Applied Biosystems 7900HT Fast 
Detection System using 40 cycles of 
amplification with alternating 15 sec, 
95oC denaturation and 1 min, 60oC 
anneal/extension cycles.
Circulating Glucose Quantification
Media samples were used to 
quantify glucose concentration (Enzy-
ChromTM Glucose Assay Kit, Bioassay 
Systems) which were based on glucose 
oxidase and color reactions. The opti-
cal density of samples was read at OD 
570 nm.
Statistical Analysis
Relative abundance of SGLT-1 
mRNA in IPEC-J2 cells was calculated 
by ΔΔCT method using the average 
ΔCT values of cells from control wells 
as the reference expression. These 
ΔΔCT values were analyzed using the 
MIXED procedure (SAS Inst. Inc., 
Cary, N.C.) to determine effects of 
SGLT-1 relative gene expression. The 
model consisted of the main effects 
of LPS, lactose, time, and their inter-
actions. For glucose concentration 
quantification, the statistical model 
included effects of LPS, lactose, direc-
tion, time, and their interactions. 
Results and Discussion
SGLT-1 mRNA Gene Expression in 
IPEC-J2 Cells
Relative abundance SGLT-1 
mRNA of each treatment was shown 
in comparison with the control wells 
which have relative abundance SGLT-1 
mRNA equal to one. There were no 
interactions of LPS × lactose × time 
(Figure 1A) or their two-way interac-
tions. However, a main effect of lactose 
on increasing relative abundance of 
SGLT-1 mRNA (P < 0.01) in IPEC-
J2 cells was detected when averaged 
across all time points (Figure 1B). 
Cells treated with a high concentration 
of lactose had greater SGLT-1 mRNA 
compared to the control (P = 0.003) 
and low lactose concentration  
(P = 0.02). This result agrees with pre-
vious research that reported feeding 
high glucose and galactose increased 
SGLT-1 mRNA abundance in mice. In 
addition, research also indicated that 
mRNA expression of SGLT-1 may be 
affected within hours, to one to three 
days after feeding a high-carbohydrate 
diet. Lastly, there were no differences 
Figure 1. Effects of supplementation of crystalline lactose on relative abundance of SGLT-1 mRNA after 3, 6, 12, and 24 hours following treatment 
additions . Each bar represents the least-squares mean (± SEM) of three replications. Panel A represents the interactive time × LPS × lactose  
(P = 0.95) means. Panel B represents the main effects of lactose (P < 0.01).
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between control cells and cells treated 
with low lactose concentration on rela-
tive abundance of SGLT-1 mRNA. 
Glucose Concentration in IPEC-J2 Cell 
Culture Media
Figures 2 and 3 illustrate the effects 
of supplementation of low and high 
concentration of crystalline lactose on 
glucose concentration in IPEC-J2 cell 
culture media at 3, 6, 12 and 24 hours 
following the addition of the respective 
treatments. There was no LPS × lactose 
× direction × time interaction (Figure 
2). However, there was a LPS × lactose 
× direction interaction tendency 
(P = 0.07) when averaged across all 
time points (P = 0.07; Figure 3A). 
Lipopolysaccharide-treatment tended 
to inhibit glucose transport to the baso-
lateral compartment compared to con-
trol wells. However, supplementation 
of lactose in LPS-treated cells tended 
to reduce (P = 0.07) the LPS-mediated 
inhibitory effect of glucose transport 
from the apical to the basolateral com-
partment.
As expected, glucose transport 
in IPEC-J2 was polarized basolater-
ally rather than apically (9,141vs. 
8,888 μM; P = 0.04; Figure 3C). The 
polarization of glucose transport 
basolaterally , followed a time-
dependent pattern (direction × time, 
P < 0.001; Figure 3B). At 24 hours, 
glucose in the apical media (7,650 μM) 
was signifi cantly decreased compared 
to the basolateral (9,353 μM) media 
and compared to 3, 6, and 12 hour 
apical media. In addition, glucose in 
the basolateral media at 24 hours was 
signifi cantly greater compared to baso-
lateral media at other timepoints.
Conclusions
This research indicates that 
crystalline lactose affects the expres-
sion of SGLT-1 mRNA, polarized 
glucose transport, and may restore 
LPS-induced reduction of basolateral 
glucose transport in vitro in model 
porcine jejunal epithelial cells. 
1Huyen Tran, graduate student; Phillip 
S. Miller, professor, and Thomas E. Burkey, 
assistant professor, Animal Science Department, 
University of Nebraska–Lincoln.
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Figure 2. Effects of supplementation of low and high concentration of crystalline lactose on glucose concentration in IPEC-J2 cell culture media at 3, 6, 
12, 24 hours following addition of treatments (P = 0.21). Each bar represents the least-squares means (± SEM) of three replications.
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Figure 3. Effects of supplementation of low and high concentrations of crystalline lactose on glucose concentration in IPEC-J2 cells. Panel A represents 
interactive LPS × lactose × direction (P = 0.07) means. Panel B represents interactive direction x time (P < 0.001) means. Panel C represents 
polarized glucose transport (direction) among all timepoints and treatments (P = 0.04).
